-
EP3455237
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3455237
| EP3455237 - MATERIALS AND METHODS FOR TREATING CANCER [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 26.11.2021 Database last updated on 22.08.2024 | |
| Former | Examination is in progress Status updated on 15.05.2020 | ||
| Former | Request for examination was made Status updated on 15.02.2019 | ||
| Former | The international publication has been made Status updated on 17.11.2017 | Most recent event Tooltip | 26.11.2021 | Application deemed to be withdrawn | published on 29.12.2021 [2021/52] | Applicant(s) | For all designated states Mayo Foundation for Medical Education and Research 200 First Street S.W. Rochester, MN 55905 / US | [2019/12] | Inventor(s) | 01 /
HUANG, Haojie 2247 Ponderosa Drive SW Rochester, Minnesota 55902 / US | [2019/12] | Representative(s) | Fish & Richardson P.C. Highlight Business Towers Mies-van-der-Rohe-Straße 8 80807 München / DE | [N/P] |
| Former [2019/12] | Kunz, Herbert Fish & Richardson P.C. Highlight Business Towers Mies-van-der-Rohe-Straße 8 80807 München / DE | Application number, filing date | 17796518.3 | 08.03.2017 | [2019/12] | WO2017US21352 | Priority number, date | US201662335785P | 13.05.2016 Original published format: US 201662335785 P | [2019/12] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2017196442 | Date: | 16.11.2017 | Language: | EN | [2017/46] | Type: | A1 Application with search report | No.: | EP3455237 | Date: | 20.03.2019 | Language: | EN | The application published by WIPO in one of the EPO official languages on 16.11.2017 takes the place of the publication of the European patent application. | [2019/12] | Search report(s) | International search report - published on: | US | 16.11.2017 | (Supplementary) European search report - dispatched on: | EP | 22.01.2019 | Classification | IPC: | C07K7/00, A61P35/00 | [2019/12] | CPC: |
C07K14/4702 (EP,US);
A61P35/00 (EP,US);
A61K38/00 (EP,US)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2019/12] | Title | German: | MATERIALIEN UND VERFAHREN ZUR BEHANDLUNG VON KREBS | [2019/12] | English: | MATERIALS AND METHODS FOR TREATING CANCER | [2019/12] | French: | COMPOSITIONS ET PROCÉDÉS POUR LE TRAITEMENT DU CANCER | [2019/12] | Entry into regional phase | 07.12.2018 | National basic fee paid | 07.12.2018 | Search fee paid | 07.12.2018 | Designation fee(s) paid | 07.12.2018 | Examination fee paid | Examination procedure | deleted | Date on which the examining division has become responsible | 07.12.2018 | Examination requested [2019/12] | 19.08.2019 | Amendment by applicant (claims and/or description) | 19.05.2020 | Despatch of a communication from the examining division (Time limit: M04) | 24.09.2020 | Reply to a communication from the examining division | 25.03.2021 | Despatch of a communication from the examining division (Time limit: M04) | 05.08.2021 | Application deemed to be withdrawn, date of legal effect [2021/52] | 25.08.2021 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2021/52] | Fees paid | Renewal fee | 07.12.2018 | Renewal fee patent year 03 | 27.03.2020 | Renewal fee patent year 04 | 29.03.2021 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X] - PAN CHUNWU ET AL, "MP55-01 CYTOPLASMIC FOXO1 NEGATIVELY REGULATES ERK TO OVERCOME TAXOL RESISTANCE IN PROSTATE CANCER", JOURNAL OF UROLOGY, (20150517), vol. 193, no. 4, doi:10.1016/J.JURO.2015.02.2044, ISSN 0022-5347, XP029151376 [X] 1,15 * the whole document * DOI: http://dx.doi.org/10.1016/j.juro.2015.02.2044 | [A] - TOMOKO KANAO ET AL, "Activation of FoxO by LRRK2 induces expression of proapoptotic proteins and alters survival of postmitotic dopaminergic neuron in Drosophila", HUMAN MOLECULAR GENETICS, gb, (20100712), vol. 19, no. 19, doi:10.1093/hmg/ddq289, ISSN 0964-6906, pages 3747 - 3758, XP055540153 [A] 1-15 * abstract * * left column; page 3749 * DOI: http://dx.doi.org/10.1093/hmg/ddq289 | [AD] - CHENGFU YUAN ET AL, "The function of FOXO1 in the late phases of the cell cycle is suppressed by PLK1-mediated phosphorylation", CELL CYCLE, US, (20140109), vol. 13, no. 5, doi:10.4161/cc.27727, ISSN 1538-4101, pages 807 - 819, XP055540156 [AD] 1-15 * right column; page 810 * DOI: http://dx.doi.org/10.4161/cc.27727 | [T] - CHUN-WU PAN ET AL, "AKT-phosphorylated FOXO1 suppresses ERK activation and chemoresistance by disrupting IQGAP1-MAPK interaction", THE EMBO JOURNAL 17 DEC 2014, (20170309), vol. 36, no. 8, doi:10.15252/embj.201695534, ISSN 1460-2075, pages 995 - 1010, XP055540157 [T] * the whole document * DOI: http://dx.doi.org/10.15252/embj.201695534 | International search | [XY]CN104610435 (XINHUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG U) [X] 1-4, 7-8, 42-43 * pg 2, para 7-9, pg 3, para 1, pg 5, para 1-2, Figures 2, 3 * [Y] 9-11; | [Y]US2014212510 (HICKEY ROBERT J [US], et al) [Y] 9-11 * para [0003], [0018], [0021] * |